Stay updated on AHCL System with Lyumjev® in Type 1 - Clinical Trial
Sign up to get notified when there's something new on the AHCL System with Lyumjev® in Type 1 - Clinical Trial page.

Latest updates to the AHCL System with Lyumjev® in Type 1 - Clinical Trial page
- Check4 days agoChange DetectedMedtronic Diabetes is replaced by Medtronic MiniMed, Inc. as sponsor, and the study revision is updated to v3.5.2.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision history shows the addition of v3.5.0 and the removal of v3.4.3.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded a new revision entry v3.4.3 and removed v3.4.2 from the record history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page has a new revision entry: Revision: v3.4.2. The deletions remove a government funding lapse notice and a prior revision note (v3.4.1), which are administrative and do not change the trial data.SummaryDifference0.8%

- Check76 days agoChange DetectedAdded a site-wide funding/status notice and a new version tag v3.4.1. Removed the previous version tag v3.4.0.SummaryDifference0.8%

- Check83 days agoChange DetectedThe page now shows a glossary toggle, color-coded indicators for additions and deletions, and an updated revision label to v3.4.0, including capitalization changes in 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

Stay in the know with updates to AHCL System with Lyumjev® in Type 1 - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AHCL System with Lyumjev® in Type 1 - Clinical Trial page.